Get Started
Multiple Sclerosis Curricula
Step 1
These independent CME/CE activities are supported by educational grants from Biogen Idec

Genentech, Inc

Novartis Pharmaceuticals Corporation

Teva Neuroscience

The Advanced Certificate Program in
Multiple Sclerosis Management
  1. Course List
faculty image
Fred D. Lublin, MD
  • Saunders Family Professor of
  •   Neurology
  • The Corinne Goldsmith Dickinson
  •   Center for Multiple Sclerosis
  • Mount Sinai School of Medicine
  • New York, NY
  • faculty image
    Aaron E. Miller, MD
  • Professor of Neurology and
  •   Medical Director
  • The Corinne Goldsmith Dickinson
  •   Center for Multiple Sclerosis
  • Mount Sinai School of Medicine
  • New York, NY
  • Fred D. Lublin, MD, and Aaron Miller, MD, co-chair this free, yearlong CME/CE program offering state-of-the-science information on the diagnosis, treatment, and management of multiple sclerosis (MS). Curriculum topics include the genetic basis of MS, the role of specific environmental factors in the pathophysiology of the disease, the importance of early treatment, novel therapies on the horizon, findings from recent clinical trials, and practical management strategies. Learn more and enroll today!
  • Assess the etiology, pathophysiology, and diagnosis of MS in order to determine appropriate treatment approaches that improve patient outcomes.
  • Apply knowledge of magnetic resonance imaging (MRI) and markers to diagnose, monitor intervention, and determine disease progression to formulate treatment strategies for patients with MS.
  • Determine the appropriate use of current and emerging MS agents in treatment strategies for MS patients that improve outcomes through knowledge of their MOA, efficacy, and safety.
  • Customize therapies for MS patients based on an understanding of their form of MS, symptoms, concomitant medications, co-morbidities, and compliance to improve their response.
  • Integrate therapies that offer improved compliance based on knowledge of the various agents, their mode of administration, and patients’ preferences to ensure more-successful treatment regimens.
    • Clinical trials versus real-world treatment regimens
    • Customizing MS therapies
    • Strategies for treatment-related side-effect management
    • Strategies for managing suboptimal responders
    • Injectable versus oral MS therapies
    • Immunopathology and inflammation in MS
    • Mechanism for altering the natural history of MS
    • Advances in the role of MRIs in MS
    • Current and emerging MS treatments
    • Monitoring disease progression, side effects of therapy, and adherence to treatment
    • Case studies—expert insights into challenging MS cases

    Target Audience

    This series of activities is designed for neurologists and other clinicians who specialize in and care for patients with multiple sclerosis.


    Activity Goal

    The goal of these CME/CE activities is to examine current and emerging strategies for treating and managing patients with multiple sclerosis.